FUSCO, ALFREDO
 Distribuzione geografica
Continente #
NA - Nord America 8.813
EU - Europa 4.243
AS - Asia 3.092
AF - Africa 73
SA - Sud America 17
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.245
Nazione #
US - Stati Uniti d'America 8.606
SG - Singapore 1.676
CN - Cina 1.222
IT - Italia 1.011
UA - Ucraina 709
IE - Irlanda 629
FI - Finlandia 542
DE - Germania 376
SE - Svezia 365
NL - Olanda 308
CA - Canada 205
GB - Regno Unito 139
RU - Federazione Russa 87
VN - Vietnam 78
CI - Costa d'Avorio 72
IN - India 42
IR - Iran 30
FR - Francia 25
BR - Brasile 16
HK - Hong Kong 15
LT - Lituania 12
BE - Belgio 11
CZ - Repubblica Ceca 8
TR - Turchia 8
ES - Italia 6
JP - Giappone 5
AU - Australia 4
PH - Filippine 4
AT - Austria 3
RO - Romania 3
BD - Bangladesh 2
BG - Bulgaria 2
CH - Svizzera 2
EU - Europa 2
KR - Corea 2
MX - Messico 2
TW - Taiwan 2
BO - Bolivia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 16.245
Città #
Chandler 1.581
Singapore 1.355
Jacksonville 832
Princeton 531
Millbury 506
Santa Clara 460
Nanjing 370
Woodbridge 326
Amsterdam 294
Ashburn 290
Wilmington 243
Boston 230
Naples 216
Ottawa 181
Beijing 163
Napoli 148
Nanchang 141
Ann Arbor 132
Houston 128
Shenyang 91
Des Moines 80
Hebei 77
Dong Ket 76
Falls Church 76
Boardman 75
Norwalk 73
Kronberg 65
Jiaxing 59
Tianjin 59
Dublin 54
Munich 48
Kunming 45
Cagliari 42
Changsha 42
Seattle 34
Aversa 31
Indiana 31
San Mateo 31
Washington 30
Lawrence 25
Toronto 24
Augusta 23
Hangzhou 22
Helsinki 20
Moscow 20
New York 19
Los Angeles 18
Leawood 17
Ardabil 15
Formia 15
Hong Kong 15
Shanghai 15
Caserta 14
Dallas 14
Orange 14
Frankfurt am Main 13
Changchun 12
London 12
Pune 12
Pozzuoli 11
Redmond 10
Rome 10
Tehran 10
Brussels 9
Lanzhou 9
Guangzhou 8
Milan 8
Mountain View 8
Prineville 8
Springfield 8
Tappahannock 8
Fort Worth 7
Monmouth Junction 7
Brno 6
Dearborn 6
Fairfield 6
Nuremberg 6
Redwood City 6
Torino 6
Hanover 5
Jinan 5
Portici 5
San Francisco 5
Simi Valley 5
Zhengzhou 5
Apex 4
Arienzo 4
Buffalo 4
Caivano 4
Castellammare di Stabia 4
Florence 4
Fu'an 4
General Trias 4
Little Rock 4
Marano Di Napoli 4
Mumbai 4
New Delhi 4
Salerno 4
Sandston 4
Afragola 3
Totale 9.831
Nome #
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation. 81
Phosphorylation of high-mobility group protein A2 by Nek2 kinase during the first meiotic division in mouse spermatocytes. 77
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas 75
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity 71
HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression. 71
A ceRNA circuitry involving the long noncoding RNA Klhl14-AS, Pax8 and Bcl2 drives thyroid carcinogenesis 71
HMGA1 protein expression sensitizes cells to cisplatin-induced cell death. 70
High mobility group A1 protein modulates autophagy in cancer cells. 69
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients 68
A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor 67
Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells. 66
Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. 66
IFN-gamma gene expression is controlled by the architectural transcription factor HMGA1. 66
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs 65
The complex CBX7-PRMT1 has a critical role in regulating E-cadherin gene expression and cell migration 64
Increased BDNF promoter methylation in the wernicke area of suicide subjects. 63
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration 62
Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation. 61
A differential proteomic approach to identify proteins associated with thyroid cell transformation. 61
Expression, purification, and characterization of rat protein tyrosine phosphatase eta catalytic domain. 61
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. 60
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. 59
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase 59
New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma 59
Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy. 58
An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. 58
CBX7 and HMGA1b proteins act in opposite way on the regulation of the SPP1 gene expression 58
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 58
High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2). 57
Familial cancer associated with a polymorphism in ARLTS1. 57
Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. 57
20 years of RET/PTC in thyroid cancer: clinico-pathological correlations. 57
HMGA1 overexpression is associated with a particular subset of human breast carcinomas 57
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. 56
Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations 56
UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. 56
45th Annual Meeting of the Italian Cancer Society 55
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells 55
TRANSCRIPTIONAL PROFILE OF KI-RAS-INDUCED TRANSFORMATION OF THYROID CELLS. 54
Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype 54
Hmga2 is necessary for Otx2-dependent exit of embryonic stem cells from the pluripotent ground state 54
Roles of HMGA proteins in cancer. 53
Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase. 53
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes 52
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice 52
Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes 52
HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells 52
Differential HMGA expression and post-translational modifications in prostatic tumor cells. 51
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. 51
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas. 51
Identification of a chimeric gene frequently activated in human thyroid papillary carcinomas 51
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 51
Role of Dicer1 in thyroid cell proliferation and differentiation 51
Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas 51
The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. 50
Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage. 50
UbcH10 is overexpressed in malignant breast carcinomas. 50
UbcH10 expression in human lymphomas. 50
Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells. 50
NCOA4 inhibits initiation of DNA replication to maintain genome stability 50
Ccdc6 knock-in mice develop thyroid hyperplasia associated to an enhanced CREB1 activity 50
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells. 50
A new mechanism of BRAF activation in human thyroid papillary carcinomas 49
DNA damage, homology-directed repair, and DNA methylation. 49
The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity 49
CBX7 is a tumor suppressor in mice and humans. 49
High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy. 48
FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. 48
Activation of RET oncogene and thyroid carcinogenesis 48
Critical role of the HMGA2 gene in pituitary adenomas. 48
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. 48
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 48
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment 47
Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer. 46
Activated ret oncogene products induce maturation-promoting factor activation in Xenopus oocytes. 46
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases 46
Association between the expression of E1 A oncogene and increased sensitivity to growth inhibition induced by sustained levels of cAMP in rat thyroid cells 46
CDH-16 gene expression in thyroid cell differentiation and transformation 46
Loss of one or two PATZ1 alleles has a critical role in the progression of thyroid carcinomas induced by the RET/PTC1 oncogene 46
Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo. 45
The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas. 45
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. 45
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells 45
A mutated p53 gene alters thyroid cell differentiation 45
Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors 45
CBX7 modulates the expression of genes critical for cancer progression. 45
NCOA4 transcriptional coactivator inhibits activation of DNA replication origins. 45
High mobility group a proteins as tumor markers 45
Translational regulation of a novel testis-specific RNF4 transcript. 44
Mitogenic and dedifferentiating effect of the K-fgf/hst oncogene on rat thyroid PC clone 3 epithelial cells. 44
Association between the expression of E1A oncogene and increased sensitivity to growth inhibition induced by sustained levels of cAMP in rat thyroid cells 44
Neoplastic transformation of rat thyroid cells requires the JunB and Fra1 gene induction which is dependent on the HMGI-C gene products. 44
Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. 44
Rnf4 is a growth inhibitor expressed in germ cells but not in human testicular tumors 44
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization 43
The PTC oncogene is able to dedifferentiate a rat thyroid epithelial cell line in culture 43
Upregulation of miR-21 by Ras in vivo and its role in tumor growth 43
Molecular cloning of PTC,a new oncogene found activated in human thyiroid papillary carcinomas and their lymph node metastates 43
Critical role of HMGA proteins in regulation of ATM expression and in cellular response to DNA damage. 43
Wnt4 inhibits cell motility induced by oncogenic Ras 43
Totale 5.354
Categoria #
all - tutte 83.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020638 0 0 0 0 0 10 16 62 5 88 212 245
2020/20211.868 18 149 268 158 172 300 153 10 185 47 311 97
2021/20222.728 40 0 1 15 24 98 31 89 632 169 516 1.113
2022/20233.457 599 266 74 410 357 409 4 305 546 301 140 46
2023/20242.026 96 314 277 136 88 161 49 229 10 32 431 203
2024/20252.694 782 953 53 81 298 527 0 0 0 0 0 0
Totale 16.858